Salarius Pharmaceuticals ... (SLRX)
undefined
undefined%
At close: undefined
1.41
-4.73%
After-hours Dec 13, 2024, 06:07 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -12.54M -31.61M -12.77M -7.35M -6.94M -21.92M -34.43M -39.49M -29.14M -
Depreciation & Amortization 10.05K 6.68K 19.18K 18.06K 127.41K 228.16K 324.55K 277.23K 49.88K -
Stock-Based Compensation 524.84K 796.80K 559.04K 319.39K 751.62K 1.94M 4.22M 6.57M 6.60M -
Other Working Capital -193.35K 1.06M 2.35M -3.04M -3.69M -2.45M 1.39M 728.34K 1.11M -
Other Non-Cash Items 130.00K 10.84M -44.69K -258.55K -1.31M 20.31K 1.78K 3.43K 4.12K -
Deferred Income Tax - - - - - 11.54K -68.14K 16.16K 9.52K -
Change in Working Capital -968.33K 2.37M 2.03M -3.04M -4.21M -3.88M 2.23M 571.46K 1.73M -
Operating Cash Flow -12.85M -17.60M -10.20M -10.31M -11.58M -23.60M -27.72M -32.05M -20.75M -
Capital Expenditures -3 -1.50M - -2.60K - - -113.50K -559.38K -265.62K -
Acquisitions - - - - 5.61M - 5.34K 5.25K - -
Purchase of Investments - - - - - -2.00M -32.99M -38.68M -39.40M -
Sales Maturities Of Investments - - - - - 16.12M 57.59M 27.00M 12.40M -
Other Investing Acitivies - -1.50M - - 204.27K 4.80K 5.34K 5.25K - -
Investing Cash Flow - -1.50M - -2.60K 5.61M 14.12M 24.49M -12.24M -27.27M -
Debt Repayment -280.92K - - - - - - - - -
Common Stock Repurchased - - - - - - - - - -
Dividend Paid - - - - -133.59K - - - - -
Other Financial Acitivies - - 28.30M 17.69M -417.88K - - - 400.00K -
Financial Cash Flow 6.64M 1.99M 28.30M 17.69M 3.58M 118.01K 2.63K 22.10K 80.84M -
Net Cash Flow -6.21M -17.11M 18.10M 7.38M -2.39M -9.36M -3.23M -44.27M 32.83M -
Free Cash Flow -12.85M -19.10M -10.20M -10.31M -11.58M -23.60M -27.84M -32.61M -21.01M -